GlobeNewswire

2024-11-09 05:30

Teva to Present at the Jefferies London Healthcare Conference

TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024. The presentation will begin at 8:30 A.M. Greenwich Mean Time (3.30 A.M. Eastern Time).

To access a live webcast of the presentation, visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations.

An archived version of the webcast will be available within 24 hours after the end of the live discussion.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global pharmaceutical leader, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded development of modern medicine. For over 120 years, Teva's commitment to bettering health has never wavered. Today, the company’s global network of capabilities enables its ~37,000 employees across 58 markets to push the boundaries of scientific innovation and deliver quality medicines to help improve health outcomes of millions of patients every day. To learn more about how Teva is all in for better health, visit www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements

This document and the presentation at the conference may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace including our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, and to sustain and focus our portfolio of generics medicines; our substantial indebtedness; our business and operations in general including the impact of global economic conditions and other macroeconomic developments and the governmental and societal responses thereto; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the third quarter of 2024 and in our Annual Report on Form 10-K for the year ended December 31, 2023, including in the sections captioned "Risk Factors.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

IR Contacts Ran Meir+1 (215) 591-8912
  Yael Ashman+972 (3) 914 8262
  Sanjeev Sharma+1 (973) 658 2700 
PR Contacts Kelley Dougherty
Eden Klein
+1 (973) 832-2810
+972 (3) 906 2645

Primary Logo

source: Teva Pharmaceutical Industries Ltd

《說說心理話》親友自殺離世遺屬如何自處?身邊親友應該怎樣陪他們走出人生最低谷?► 即睇

人氣文章
最近7天
沒有相關資料。
1
港股 | 蕭猷華:內地AI發展迅速,阿里巴巴股價看俏
2
高息定存 | 一周高息合集,銀行高息搶存,富邦1個月4.88厘,華僑1年期3.6厘
3
英偉達 | DeepSeek衝擊AI晶片行業結構 英偉達暴跌仍未急抄底
4
環球央行 | 歐洲央行宣布再次減息0.25厘,符合市場預期
5
一本萬利 | 2025年的五個「勿」(有片)
6
啟德體育園明天足球賽測試,4.4萬公僕參與涉逾400萬車馬費
7
高息定存 | 華僑銀行推新春港元定存優惠,88天或188天享3.68厘
8
電騙 | 黃俊碩:多管齊下,防治內地留學生受騙
9
易經看世界 | 乙巳蛇年趨吉五招:言行注意甚麼?應遠離甚麼人?(有片)
10
PapaHome淘寶家具實體店22日開幕,選址尖沙咀中港城,料創100個就業機會
11
新世界 | 摩通:新世界若債務違約或打開行業「潘朵拉盒子」
12
專訪 | 關稅戰 | 香港物流協會副會長梁庭彰:美物流商停收包裹對跨境電商打擊重大
13
【FOCUS】螺絲殼裏做道場,DeepSeek致勝啟示
14
港股 | 午市前瞻 | iPhone SE難救中國市場 專家提醒比電已超買
15
大S | 台灣藝人徐熙媛因流感併發肺炎逝世,享年48歲
16
DeepSeek推出即上蘋果中國區榜首,能力直追OpenAI
17
收市短打 | 楊韻銳:港股升勢有成交配合 惟留意關鍵阻力位!
18
高息定存 | 一周高息合集,蛇年定存金蛇起舞,1個月定存高達8厘
19
港股 | 蕭猷華:春節假後,恒指逐步上望21000點
20
馬斯克明拆特朗普台,指其星際之門計劃「假大空」
21
【FOCUS】侵侵呼籲全球「降息」,日銀祭18年最激進加息
22
神州經脈 | 特朗普或與華討論關稅,人民幣大漲,滬指連升兩周
23
港股 | 午市前瞻 | AI應用概念炒作有錢途 下階段部署邊隻好?
24
港股 | 午市前瞻 | DeepSeek概念火爆炒起AI股 百度係時候追落後
25
DeepSeek | 從私募孵化的AI新星--DeepSeek崛起之路
26
高息定存 | 信銀國際1個月加至3.85厘,華僑一年期3.6厘
27
隱瞞「賣殼」欺詐罪成,詹培忠判囚34個月,詹劍崙囚37個月
28
阿里 | 推新AI模型聲稱超越DeepSeek,股價逆市飆逾半成仍有上升空間?
29
【FOCUS】中長期資金入市首提硬指標,健康慢牛仍需解兩難
30
魚缸博客 | Deepseek改變AI?繼續買芯片股!衝啊!
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

【etnet 30周年】多重慶祝活動一浪接一浪,好禮連環賞!

etnet榮獲第六屆國際信息商會議「最佳信息商」白金獎

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

大國博弈

2025-26年度財政預算案

貨幣攻略

說說心理話

Watch Trends 2024

北上食買玩

Art Month 2024

理財秘笈

流感高峰期

山今養生智慧

輕鬆護老